Canada markets closed

AlzeCure Pharma AB (publ) (AC6.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.1205-0.0150 (-11.07%)
At close: 10:18AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
27,594
27,707
46,183
66,715
62,356
Selling General and Administrative
10,831
10,598
10,168
11,265
9,375
Total Operating Expenses
38,580
38,344
56,569
78,143
72,022
Operating Income or Loss
-38,580
-38,344
-56,569
-78,143
-72,022
Interest Expense
8
7
4
1
1
Income Before Tax
-37,426
-37,167
-56,239
-77,781
-71,366
Income from Continuing Operations
-37,426
-37,167
-56,239
-77,781
-71,366
Net Income
-37,426
-37,167
-56,239
-77,781
-71,366
Net Income available to common shareholders
-37,426
-37,167
-56,239
-77,781
-71,366
Basic EPS
-0.65
-
-1.05
-1.83
-1.61
Diluted EPS
-0.65
-
-1.05
-1.83
-1.61
Basic Average Shares
59,249
-
53,822
42,616
44,365
Diluted Average Shares
59,324
-
54,223
43,079
44,700